Evaluation of efficacy of duloxetine and pregabalin in patients with painful diabetic peripheral neuropathy

Trial Profile

Evaluation of efficacy of duloxetine and pregabalin in patients with painful diabetic peripheral neuropathy

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2014

At a glance

  • Drugs Duloxetine (Primary) ; Pregabalin (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2014 New trial record
    • 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top